Trial Profile
A phase I trial to investigate GNR-047 for the treatment of oncohaematological diseases, such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and different kinds of non-Hodgkin's lymphoma (NHL)
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 May 2016
Price :
$35
*
At a glance
- Drugs GNR 047 (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- 11 May 2016 New trial record